» Articles » PMID: 19353674

Noninvasive Quantification of Whole-brain Cerebral Metabolic Rate of Oxygen (CMRO2) by MRI

Overview
Journal Magn Reson Med
Publisher Wiley
Specialty Radiology
Date 2009 Apr 9
PMID 19353674
Citations 127
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral metabolic rate of oxygen (CMRO(2)) is an important marker for brain function and brain health. Existing techniques for quantification of CMRO(2) with positron emission tomography (PET) or MRI involve special equipment and/or exogenous agents, and may not be suitable for routine clinical studies. In the present study, a noninvasive method is developed to estimate whole-brain CMRO(2) in humans. This method applies phase-contrast MRI for quantitative blood flow measurement and T(2)-relaxation-under-spin-tagging (TRUST) MRI for venous oxygenation estimation, and uses the Fick principle of arteriovenous difference for the calculation of CMRO(2). Whole-brain averaged CMRO(2) values in young, healthy subjects were 132.1 +/- 20.0 micromol/100 g/min, in good agreement with literature reports using PET. Various acquisition strategies for phase-contrast and TRUST MRI were compared, and it was found that nongated phase-contrast and sagittal sinus (SS) TRUST MRI were able to provide the most efficient and accurate estimation of CMRO(2). In addition, blood flow and venous oxygenation were found to be positively correlated across subjects. Owing to the noninvasive nature of this method, it may be a convenient and useful approach for assessment of brain metabolism in brain disorders as well as under various physiologic conditions.

Citing Articles

Compensatory increase in oxygen extraction fraction is associated with age-related cerebrovascular disease.

McFadden J, Matthews J, Scott L, Herholz K, Dickie B, Haroon H Neuroimage Clin. 2025; 45:103746.

PMID: 39922028 PMC: 11849109. DOI: 10.1016/j.nicl.2025.103746.


Simultaneous and cumulative effects of tDCS on cerebral metabolic rate of oxygen in multiple sclerosis.

Muccio M, Pilloni G, Walton Masters L, He P, Krupp L, Datta A Front Hum Neurosci. 2024; 18:1418647.

PMID: 39081842 PMC: 11286420. DOI: 10.3389/fnhum.2024.1418647.


Laminar multi-contrast fMRI at 7T allows differentiation of neuronal excitation and inhibition underlying positive and negative BOLD responses.

Shao X, Guo F, Kim J, Ress D, Zhao C, Shou Q medRxiv. 2024; .

PMID: 39040201 PMC: 11261924. DOI: 10.1101/2024.04.01.24305167.


Recent Advances in MR Imaging-based Quantification of Brain Oxygen Metabolism.

Wehrli F Magn Reson Med Sci. 2024; 23(3):377-403.

PMID: 38866481 PMC: 11234951. DOI: 10.2463/mrms.rev.2024-0028.


Validation of a new 3D quantitative BOLD based cerebral oxygen extraction mapping.

Lee H, Xu J, Fernandez-Seara M, Wehrli F J Cereb Blood Flow Metab. 2024; 44(7):1184-1198.

PMID: 38289876 PMC: 11179617. DOI: 10.1177/0271678X231220332.


References
1.
Davis T, Kwong K, Weisskoff R, Rosen B . Calibrated functional MRI: mapping the dynamics of oxidative metabolism. Proc Natl Acad Sci U S A. 1998; 95(4):1834-9. PMC: 19199. DOI: 10.1073/pnas.95.4.1834. View

2.
Attwell D, Laughlin S . An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab. 2001; 21(10):1133-45. DOI: 10.1097/00004647-200110000-00001. View

3.
Golay X, Silvennoinen M, Zhou J, Clingman C, Kauppinen R, Pekar J . Measurement of tissue oxygen extraction ratios from venous blood T(2): increased precision and validation of principle. Magn Reson Med. 2001; 46(2):282-91. DOI: 10.1002/mrm.1189. View

4.
Mintun M, Raichle M, Martin W, Herscovitch P . Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. J Nucl Med. 1984; 25(2):177-87. View

5.
Hattori N, Bergsneider M, Wu H, Glenn T, Vespa P, Hovda D . Accuracy of a method using short inhalation of (15)O-O(2) for measuring cerebral oxygen extraction fraction with PET in healthy humans. J Nucl Med. 2004; 45(5):765-70. View